Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against <i>MYCN</i>-Amplified Neuroblastoma.

Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against MYCN-Amplified Neuroblastoma.

Bellamy, Jacob; Szemes, Marianna; Melegh, Zsombor; Dallosso, Anthony; Kollareddy, Madhu; Catchpoole, Daniel; Malik, Karim.

Afiliação

Bellamy J; Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Szemes M; Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Melegh Z; Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Dallosso A; Department of Cellular Pathology, Southmead Hospital, Bristol, United Kingdom.
Kollareddy M; Department of Cellular Pathology, Southmead Hospital, Bristol, United Kingdom.
Catchpoole D; Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Malik K; The Kids Research Institute, The Children's Hospital at Westmead, Westmead, NSW, Australia.

Front Oncol ; 10: 818, 2020.

Article em En | MEDLINE | ID: mdl-32537432